5'-ODMTr-2'-OMe-A(Pac)-3'-CE-phosphoramidite
5'-ODMTr-2'-OMe-A(Pac)-3'-CE-phosphoramidite - N (Normal) is backordered and will ship as soon as it is back in stock.
Couldn't load pickup availability
Shipping notes
Shipping notes
Related Products
Specifications
Specifications
-
Catalog No.PR1-116
-
SMILESO=C(COC1=CC=CC=C1)NC2=NC=NC3=C2N=CN3[C@H]4[C@H](OC)[C@H](OP(N(C(C)C)C(C)C)OCCC#N)[C@@H](COC(C5=CC=CC=C5)(C6=CC=C(OC)C=C6)C7=CC=C(OC)C=C7)O4
-
Molecular FormulaC49H56N7O9P
-
Molecular Weight918.00
-
AppearanceReport result
-
PurityHPLC≥97%
-
Storage Condition-20℃
Documentation
Documentation
-
Catalog No.PR1-116
-
SMILESO=C(COC1=CC=CC=C1)NC2=NC=NC3=C2N=CN3[C@H]4[C@H](OC)[C@H](OP(N(C(C)C)C(C)C)OCCC#N)[C@@H](COC(C5=CC=CC=C5)(C6=CC=C(OC)C=C6)C7=CC=C(OC)C=C7)O4
-
Molecular FormulaC49H56N7O9P
-
Molecular Weight918.00
-
AppearanceReport result
-
PurityHPLC≥97%
-
Storage Condition-20℃
Why choose Hongene?
Trusted Partner in Nucleic Acid
Integrated Supply & Commercial Scale
With 26+ years of expertise, we control a secure supply chain for RNA raw materials and provide reliable GMP-grade oligo synthesis from research to commercial kilogram-scale production.
Proprietary Technology & IP
Our proprietary Chemoenzymatic Ligation Platform combines chemical andenzymatic methods, enabling high-putity, cost-effective, and large-scale production of RNA-based therapeutics.
Rigorous Quality
We implement multiple stringent QC steps, maintain ISO certifications, and ensure >99% batch-to-batch consistency, reducing scale-up and PPQ risks.
Manufacturing Scalability
Hongene operates 1.67 million sq. ft Oligonucleotide Manufacturing Facility, with advanced equipments including multiple OligoPilot™ and OligoProcess™ synthesizers (10-1800 mmol). 48 flexible production lines enable one-stop seamless scaling-up of API production from gram-level to tons and acheive high purity of 98%, meeting NMPA, FDA, and EMA standards.
Global Business Network
Our products and services reach over 40 countries and regions, supporting around 3,000 clients worldwide.
